SFS
KRTX

Sowell Financial Services’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Sowell Financial Services’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$1K – 2926
2021
Q1 		$1K Buy
+6
New +$680 ﹤0.01% 3043
2020
Q1 		– Sell
-500
Closed -$38K – 2752
2019
Q4 		$38K Buy
+500
New +$21.9K ﹤0.01% 1238

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Sowell Financial Services's KRTX Position: Q2 2021 in Review

Sowell Financial Services sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2021, closing a stake of 6 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in KRTX in Q4 2019 and held it in 2 quarters. The position peaked at $38K in Q4 2019. 159 funds tracked by Wall St. Rank hold KRTX as of Q2 2021.

  • Sowell Financial Services reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 6 Karuna Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Sowell Financial Services's Karuna Therapeutics, Inc. Common Stock position peaked at $38K in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.